December 15, 2006

In a letter to VeriChip Corporation, a subsidiary of Applied Digital Solutions (Nasdaq: ADSX - News), the National Stroke Association (NSA) has recognized that implantable RFID microchip technology offers the ability to improve stroke treatment by providing medical professionals with immediate access to vital health information of stroke-afflicted patients. An excerpt from the letter, signed by James Baranski, CEO of the National Stroke Association, states, "Personal Health Records, including implantable RFID microchips such as VeriMed, could play a critical role in assisting medical professionals in delivering appropriate stroke treatment promptly, leading to better patient outcomes." The VeriMed Patient Identification System which consists of a handheld radio frequency identification (RFID) scanner, an implantable RFID microchip and a secure patient database, is being used to help rapidly identify and provide access to important health information on participating patients who arrive at an emergency department unconscious, delirious or unable to communicate. This implantable RFID system is the only system of its type cleared by the United States Food and Drug Administration for use in people.

posted by Robert Benjamin